Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission.

Okayasu H, Sutter RW, Czerkinsky C, Ogra PL.

Vaccine. 2011 Oct 26;29(46):8205-14. doi: 10.1016/j.vaccine.2011.08.059. Epub 2011 Sep 5. Review.

PMID:
21896299
2.
3.
4.

[Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].

Delpeyroux F, Guillot S, Szendröi A, Balanant J, Caro V, Cuervo N, Chevaliez S, Dahourou G, Crainic R.

Bull Soc Pathol Exot. 2000 Jul;93(3):193-7. Review. French.

PMID:
11030056
5.

Poliomyelitis: eradication in sight.

Melnick JL.

Epidemiol Infect. 1992 Feb;108(1):1-18. Review.

6.

Epidemiology of poliomyelitis--options and update.

Dutta A.

Vaccine. 2008 Oct 23;26(45):5767-73. doi: 10.1016/j.vaccine.2008.07.101. Epub 2008 Aug 26. Review.

PMID:
18755232
7.

A case for developing antiviral drugs against polio.

Collett MS, Neyts J, Modlin JF.

Antiviral Res. 2008 Sep;79(3):179-87. doi: 10.1016/j.antiviral.2008.04.002. Epub 2008 May 13. Review.

PMID:
18513807
8.

Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.

Ghendon Y, Robertson SE.

Bull World Health Organ. 1994;72(6):973-83. Review.

9.

Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.

Minor P.

Vaccine. 2009 May 5;27(20):2649-52. doi: 10.1016/j.vaccine.2009.02.071. Epub 2009 Mar 3. Review.

PMID:
19428874
10.

[Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis].

Blondel B, Autret A, Brisac C, Pelletier I, Martin-Latil S, Jegouic S, Bessaud M, Joffret ML, Balanant J, Colbère-Garapin F, Delpeyroux F.

Med Trop (Mars). 2008 Apr;68(2):189-202. Review. French.

PMID:
18630055
11.

[The lost decade of global polio eradication and moving forward].

Shimizu H.

Uirusu. 2010 Jun;60(1):49-58. Review. Japanese.

12.

Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.

Sabin AB.

Eur J Epidemiol. 1991 Mar;7(2):95-120. Review. Erratum in: Eur J Epidemiol 1991 May;7(3):310.

PMID:
1646116
14.

Risk management in a polio-free world.

Bruce Aylward R, Sutter RW, Cochi SL, Thompson KM, Jafari H, Heymann D.

Risk Anal. 2006 Dec;26(6):1441-8. Review.

PMID:
17184391
15.

Poliomyelitis eradication: progress, challenges for the end game, and preparation for the post-eradication era.

Sutter RW, Tangermann RH, Aylward RB, Cochi SL.

Infect Dis Clin North Am. 2001 Mar;15(1):41-64. Review.

PMID:
11301822
17.

Eradicating polio: it's feasibility in near future?

Singh P, Das JK, Dutta PK.

J Commun Dis. 2008 Dec;40(4):225-32. Review.

PMID:
19579713
18.

World wide experience with inactivated poliovirus vaccine.

Bonnet MC, Dutta A.

Vaccine. 2008 Sep 15;26(39):4978-83. doi: 10.1016/j.vaccine.2008.07.026. Epub 2008 Aug 3. Review.

PMID:
18680777
19.

Polio eradication, cessation of vaccination and re-emergence of disease.

Minor PD.

Nat Rev Microbiol. 2004 Jun;2(6):473-82. Review. No abstract available.

PMID:
15152203
20.

Future of polio vaccines.

Ehrenfeld E, Modlin J, Chumakov K.

Expert Rev Vaccines. 2009 Jul;8(7):899-905. doi: 10.1586/erv.09.49. Review.

Supplemental Content

Support Center